Tabula Rasa Healthcare Inc. (TRHC)

39.70
0.21 0.53
NASDAQ : Technology Services
Prev Close 39.91
Open 39.89
Day Low/High 39.06 / 40.15
52 Wk Low/High 11.59 / 42.79
Volume 86.80K
Avg Volume 370.90K
Exchange NASDAQ
Shares Outstanding 20.01M
Market Cap 830.54M
EPS 0.80
P/E Ratio 54.61
Div & Yield N.A. (N.A)

Latest News

Dr. George Brett Named Senior Vice President Of Consulting For Capstone Performance Systems

Dr. George Brett Named Senior Vice President Of Consulting For Capstone Performance Systems

New Organizational Structure to Improve Efficiency, Accommodate Growth

Facebook's Stock May Start to Infect the Major Indices to a Greater Degree

Facebook's Stock May Start to Infect the Major Indices to a Greater Degree

Selective stock picking continues to be rewarded but the key word here is 'selective'.

Tabula Rasa HealthCare To Exhibit And Present At APhA Annual Meeting And Exposition

Tabula Rasa HealthCare To Exhibit And Present At APhA Annual Meeting And Exposition

Five Poster Presentations. Hugo H. Schaefer Award. Exhibit Booth 140.

THRC's CEO Calvin H. Knowlton, PhD Interviewed On NPR's It's Your Health

THRC's CEO Calvin H. Knowlton, PhD Interviewed On NPR's It's Your Health

Why unintentional misuse of prescription drugs is the 4th leading cause of death in the US

5 Stocks I'm Looking to Buy on Weakness

5 Stocks I'm Looking to Buy on Weakness

This market needs a rest and the action in individual stocks looks weaker.

Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani To Receive American Pharmacists Association's Hugo H. Schaefer Award

Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani To Receive American Pharmacists Association's Hugo H. Schaefer Award

Award recognizes outstanding voluntary contributions to the APhA, the profession and society

TRHC Crosses Above Average Analyst Target

TRHC Crosses Above Average Analyst Target

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $35.71, changing hands for $35.92/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TRHC's Coding School Accepting Applications For New Veterans Scholarship

TRHC's Coding School Accepting Applications For New Veterans Scholarship

Full scholarship will improve access to 12-week immersive program

Tabula Rasa HealthCare CEO Presents At IBC Innovation Day

Tabula Rasa HealthCare CEO Presents At IBC Innovation Day

Calvin H. Knowlton, PhD Focuses on Care Coordination and Readmission Risk

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Here's what you need to know now for Wednesday, Feb. 14.

Biotech Heats Up as Fear of Missing Out Returns

Biotech Heats Up as Fear of Missing Out Returns

It's hard to believe the bounce will continue to run in V-shaped fashion.

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

Philadelphia Investment Forum Scoops The Groundhog - Delivers The Forecast A Day Early

While the world's attention turns to Pennsylvania on February 2 nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1 st for the 2018...

Hey Market, Can You Give Me a Minute to Catch My Breath?

Hey Market, Can You Give Me a Minute to Catch My Breath?

If you like buying pullbacks you are out of luck.

TRHC Crosses Above Average Analyst Target

TRHC Crosses Above Average Analyst Target

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $34.00, changing hands for $34.14/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Tabula Rasa HealthCare Reaches Analyst Target Price

Tabula Rasa HealthCare Reaches Analyst Target Price

In recent trading, shares of Tabula Rasa HealthCare Inc have crossed above the average analyst 12-month target price of $33.00, changing hands for $34.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: C (Hold)